BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22084221)

  • 1. Chemosurgery for retinoblastoma: what we know after 5 years.
    Abramson DH
    Arch Ophthalmol; 2011 Nov; 129(11):1492-4. PubMed ID: 22084221
    [No Abstract]   [Full Text] [Related]  

  • 2. Superselective intraophthalmic artery chemotherapy: what we do not know.
    Wilson MW; Haik BG; Dyer MA
    Arch Ophthalmol; 2011 Nov; 129(11):1490-1. PubMed ID: 22084220
    [No Abstract]   [Full Text] [Related]  

  • 3. Complications of intra-arterial chemotherapy for retinoblastoma.
    Monroy JE; Orbach DB; VanderVeen D
    Semin Ophthalmol; 2014; 29(5-6):429-33. PubMed ID: 25325870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
    Padrón-Pérez N; Català-Mora J
    J Fr Ophtalmol; 2014 Feb; 37(2):176. PubMed ID: 24210940
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
    Suzuki S; Yamane T; Mohri M; Kaneko A
    Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoblastoma: evidence for stage-based chemotherapy.
    Chung CY; Medina CA; Aziz HA; Singh AD
    Int Ophthalmol Clin; 2015; 55(1):63-75. PubMed ID: 25436494
    [No Abstract]   [Full Text] [Related]  

  • 7. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
    Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
    Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial chemotherapy in retinoblastoma - A paradigm change.
    Manjandavida FP; Stathopoulos C; Zhang J; Honavar SG; Shields CL
    Indian J Ophthalmol; 2019 Jun; 67(6):740-754. PubMed ID: 31124482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lecture.
    Abramson DH
    Br J Ophthalmol; 2010 Apr; 94(4):396-9. PubMed ID: 20424209
    [No Abstract]   [Full Text] [Related]  

  • 11. Intra-arterial and oral digoxin therapy for retinoblastoma.
    Patel M; Paulus YM; Gobin YP; Djaballah H; Marr B; Dunkel IJ; Brodie S; Antczak C; Folberg R; Abramson DH
    Ophthalmic Genet; 2011 Sep; 32(3):147-50. PubMed ID: 21446853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
    Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications.
    Shields CL; Bianciotto CG; Jabbour P; Griffin GC; Ramasubramanian A; Rosenwasser R; Shields JA
    Arch Ophthalmol; 2011 Nov; 129(11):1407-15. PubMed ID: 21670326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
    Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S
    Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's New in Intra-Arterial Chemotherapy for Retinoblastoma?
    Abramson DH; Francis JH; Gobin YP
    Int Ophthalmol Clin; 2019; 59(2):87-94. PubMed ID: 30908282
    [No Abstract]   [Full Text] [Related]  

  • 16. Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma.
    Fallaha N; Dubois J; Carret AS; Callejo SA; Hamel P; Superstein R
    Arch Ophthalmol; 2012 Aug; 130(8):1075-7. PubMed ID: 22893086
    [No Abstract]   [Full Text] [Related]  

  • 17. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
    Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Orbital Recurrence After Enucleation or Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma.
    de Jong MC; Kors A; de Graaf P
    JAMA Ophthalmol; 2016 Jan; 134(1):114. PubMed ID: 26583950
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
    Vajzovic LM; Murray TG; Aziz-Sultan MA; Schefler AC; Fernandes CE; Wolfe SC; Hess DJ; Dubovy SR
    Arch Ophthalmol; 2010 Dec; 128(12):1619-23. PubMed ID: 21149791
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence of Orbital Recurrence After Enucleation or Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma--Reply.
    Yannuzzi NA; Francis JH; Abramson DH
    JAMA Ophthalmol; 2016 Jan; 134(1):114-5. PubMed ID: 26584063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.